WASHINGTON—The American Medical Association, alongside groups like the American Public Health Association, launched a coordinated lobbying effort this month to push for federal mandates on autonomous vehicle technology. These medical organizations argue self-driving cars will drastically reduce the 42,795 traffic fatalities recorded in the United States in 2022. They also cite data from the National Safety Council, which estimates motor vehicle crashes cost the U.S. economy $474 billion in 2022, including medical expenses, lost wages and property damage. Framing AV adoption as a critical public health initiative, these groups aim to accelerate regulatory pathways.
This medical advocacy provides a powerful front for autonomous vehicle developers like Waymo, Cruise and Tesla. Waymo, a subsidiary of Alphabet, and Cruise, backed by General Motors, spent a combined $4.1 million lobbying Congress in 2023, according to OpenSecrets filings. Waymo reported 1.5 million miles of fully autonomous driving in Phoenix last year with zero serious injuries or fatalities. Tesla has also expanded its lobbying presence, spending $2.3 million in the same period to advocate for fewer regulatory hurdles. Lobbyists for these tech giants are now using the public health narrative to sway skeptical lawmakers and accelerate federal deployment standards.
The push pits the tech-backed medical lobby against traditional auto manufacturers and established insurance companies. General Motors and Ford face potential investment costs for new AV safety standards, while State Farm and Geico could see dramatically reduced claims if accident rates drop by the projected 90 percent cited by AV proponents. Rep. Frank Pallone Jr. chairman of the House Energy and Commerce Committee, and Sen. Maria Cantwell, chairwoman of the Senate Commerce Committee, both face intense pressure from both sides as their committees draft new transportation legislation. Each committee holds jurisdiction over key aspects of vehicle safety and technology.
Proponents of AV mandates target a potential bill in the next transportation funding package, aiming to include provisions for federal research grants, streamlined testing protocols and national AV operating frameworks. This would bypass a patchwork of state-level regulations that currently impede widespread deployment. Opponents, including the Teamsters Union, warn of job displacement for commercial drivers and raise concerns about untested technology. The union spent $1.8 million lobbying in 2023, directly countering the tech and medical groups. The debate highlights a clash between innovation and established industries on Capitol Hill, with billions in future revenue at stake.
